Formulation for deposition of silicon doped hafnium oxide as ferroelectric materials
AssigneeVersum Materials US, LLC
InventorsXinjian Lei, Matthew R. MacDonald, Moo-Sung Kim, Se-Won LEE
Life of this patent
Estimating the term…
Abstract
In one aspect, the invention is formulations comprising both organoaminohafnium and organoaminosilane precursors that allows anchoring both silicon-containing fragments and hafnium-containing fragments onto a given surface having hydroxyl groups to deposit silicon doped hafnium oxide having a silicon doping level ranging from 0.5 to 8 mol %, preferably 2 to 6 mol %, most preferably 3 to 5 mol %, suitable as ferroelectric material. In another aspect, the invention is methods and systems for depositing the silicon doped hafnium oxide films using the formulations.
Claims32
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method to deposit a film comprising silicon, hafnium and oxygen onto a substrate, comprising:
- a) providing the substrate in a reactor;
- b) introducing into the reactor a composition comprising:
- (i) at least one organoaminosilane precursor compound having a formula of RxR3Si(NR1R2)3-x;
- wherein
- R is a linear or branched C1 to C6 alkyl;
- R1, R2 and R3 are independently selected from linear or branched C1 to C6 alkyl;
- wherein
- R1 and R2 in organoamino group are linked to form a cyclic ring structure;
- or not linked to form a cyclic ring structure;
- x=0, 1, or 2;
- and
- (ii) at least one organoaminohafnium precursor compound having a formula of LxHf(NR1R2)4-x;
- wherein
- L is cyclopentadienyl or alkyl substituted cyclopentadienyl;
- R1 and R2 are independently selected from linear or branched C1 to C6 alkyl in organoamino group;
- wherein
- R1 and R2 are linked to form a cyclic ring structure or R1 and R2 are not linked to form a cyclic ring structure;
- and
- x=0, 1, or 2;
- c) purging the reactor with a purge gas;
- d) introducing an oxygen-containing source into the reactor;
- and
- e) purging the reactor with the purge gas;
- wherein
- melting point of the composition is <30° C.;
- the at least one organoaminosilane precursor and the at least one organoaminohafnium precursor have the same organoamino group;
- the oxygen-containing source is selected from the group consisting of an oxygen plasma, ozone, a water vapor, water vapor plasma, nitrogen oxide plasma, a carbon oxide plasma, and combinations thereof;
- the purge gas selected from the group consisting of argon (Ar), nitrogen (N2), helium (He), neon, hydrogen (H2), and combinations thereof;
- deposition process is selected from the group consisting of a thermal atomic layer deposition (ALD), plasma enhanced atomic layer deposition (PEALD) process, and combinations thereof;
- the method is conducted at a temperature ranging from 100° C. to 600° C.;
- and
- b) through e) are repeated until a desired thickness of film is deposited.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.